Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

10.9%

11 terminated/withdrawn out of 101 trials

Success Rate

86.7%

+0.2% vs industry average

Late-Stage Pipeline

23%

23 trials in Phase 3/4

Results Transparency

47%

34 of 72 completed trials have results

Key Signals

3 recruiting34 with results7 terminated4 withdrawn

Enrollment Performance

Analytics

N/A
36(40.0%)
Phase 2
20(22.2%)
Phase 4
16(17.8%)
Phase 1
9(10.0%)
Phase 3
7(7.8%)
Early Phase 1
2(2.2%)
90Total
N/A(36)
Phase 2(20)
Phase 4(16)
Phase 1(9)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (101)

Showing 20 of 101 trials
NCT05471011Active Not Recruiting

COVID-19 Outcome Prediction Algorithm

Role: collaborator

NCT07494084Phase 4Not Yet Recruiting

Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance

Role: collaborator

NCT05534412Not ApplicableActive Not Recruiting

A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence

Role: collaborator

NCT04175678Not ApplicableActive Not Recruiting

Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men

Role: lead

NCT02720874Not ApplicableWithdrawn

Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis

Role: lead

NCT06333041Phase 2Not Yet Recruiting

Study of Cannabidiol in Sanfilippo Syndrome

Role: lead

NCT04918719Phase 2Completed

Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke

Role: lead

NCT06453928Not ApplicableRecruiting

Starting Technology in At Risk Type 1 Diabetes Study

Role: collaborator

NCT06480578Phase 2Recruiting

An Integrated Intervention Using a Pill Ingestible Sensor System

Role: collaborator

NCT02994602Phase 1Completed

Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males

Role: collaborator

NCT03153319Phase 1Active Not Recruiting

Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI

Role: lead

NCT07353944Not ApplicableCompleted

TTNS vs PTNS in a County Hospital System.

Role: lead

NCT03136601Not ApplicableCompleted

Percutaneous Tibial Nerve Stimulation Maintenance: Monthly Therapy or Per Patient Requested Need

Role: lead

NCT05753215Phase 2Active Not Recruiting

Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection

Role: lead

NCT03637400Phase 2Completed

Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment

Role: lead

NCT04526860Not ApplicableWithdrawn

Determine if Human Infant Weight Gain Can be Modulated to Prevent Obesity

Role: lead

NCT04181294Not ApplicableCompleted

Time Limited Trials to Reduce Non-Beneficial Intensive Care Unit Treatments

Role: lead

NCT01382069Phase 1Completed

Phase 1 Study of Dimethandrolone Undecanoate in Healthy Men

Role: lead

NCT04782063Not ApplicableCompleted

Prevention of Obesity in Infants of Overweight and Obese Women

Role: lead

NCT02754687Phase 1Completed

Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men

Role: collaborator